WO2005051489A3 - Fast dissolving solid oral dosage forms of galanthamine - Google Patents

Fast dissolving solid oral dosage forms of galanthamine Download PDF

Info

Publication number
WO2005051489A3
WO2005051489A3 PCT/IB2004/003832 IB2004003832W WO2005051489A3 WO 2005051489 A3 WO2005051489 A3 WO 2005051489A3 IB 2004003832 W IB2004003832 W IB 2004003832W WO 2005051489 A3 WO2005051489 A3 WO 2005051489A3
Authority
WO
WIPO (PCT)
Prior art keywords
galanthamine
dosage forms
oral dosage
solid oral
fast dissolving
Prior art date
Application number
PCT/IB2004/003832
Other languages
French (fr)
Other versions
WO2005051489A2 (en
Inventor
Swati Aggarwal
Romi Barat Singh
Vishnubhotla Naga Prasad
Sanjeev Kumar Sethi
Original Assignee
Ranbaxy Lab Ltd
Swati Aggarwal
Romi Barat Singh
Vishnubhotla Naga Prasad
Sanjeev Kumar Sethi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Swati Aggarwal, Romi Barat Singh, Vishnubhotla Naga Prasad, Sanjeev Kumar Sethi filed Critical Ranbaxy Lab Ltd
Publication of WO2005051489A2 publication Critical patent/WO2005051489A2/en
Publication of WO2005051489A3 publication Critical patent/WO2005051489A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

The present invention relates to fast-dissolving oral dosage forms of galanthamine for oral administration and processes for the preparation thereof.
PCT/IB2004/003832 2003-11-28 2004-11-23 Fast dissolving solid oral dosage forms of galanthamine WO2005051489A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1498/DEL/2003 2003-11-28
IN1498DE2003 2003-11-28

Publications (2)

Publication Number Publication Date
WO2005051489A2 WO2005051489A2 (en) 2005-06-09
WO2005051489A3 true WO2005051489A3 (en) 2006-04-20

Family

ID=34631116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/003832 WO2005051489A2 (en) 2003-11-28 2004-11-23 Fast dissolving solid oral dosage forms of galanthamine

Country Status (1)

Country Link
WO (1) WO2005051489A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008047910A1 (en) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tabletting excipient based on lactose and cellulose

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099863A (en) * 1996-06-14 2000-08-08 Janssen Pharmaceutica N.V. Fast-dissolving galanthamine hydrobromide tablet

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6099863A (en) * 1996-06-14 2000-08-08 Janssen Pharmaceutica N.V. Fast-dissolving galanthamine hydrobromide tablet

Also Published As

Publication number Publication date
WO2005051489A2 (en) 2005-06-09

Similar Documents

Publication Publication Date Title
MXPA03006476A (en) Pharmaceutical dosage forms of epothilones for oral administration.
AU2003299826A1 (en) Pharmaceutical safety dosage forms
PL356358A1 (en) Solid dosage form of someticone for oral administration
WO2002094774A3 (en) Oxcarbazepine dosage forms
IL176452A0 (en) Effervescent oral opiate dosage form
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
WO2006131591A3 (en) An entacapone-containing oral dosage form
AU2003229555A1 (en) Oral administration form for difficulty soluble basic active ingredients which are applied orally
WO2004069198A3 (en) Sugar-free oral transmucosal solid dosage forms and uses thereof
AU2003280087A1 (en) Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton
EP2258350A3 (en) Taste masked dosage form containing roflumilast
AU2003242988A1 (en) Process for the preparation of the anti-cancer drug imatinib and its analogues
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2002341241A1 (en) Process for the preparation of fast dissolving dosage form
SG116507A1 (en) Pharmaceutical dosage form and method of making.
AU2003221699A1 (en) Pharmaceutical preparation for taste masking
WO2004098594A3 (en) Dosage form containing pantoprazole as active ingredient
HK1100352A1 (en) Solid medicament of oral administration and preparation thereof
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
EP1534295A4 (en) Formulations and methods of administration of cephalotaxines, including homoharringtonine
WO2005009407A3 (en) Oral pharmaceutical formulations of olanzapine
WO2004009085A3 (en) Taste masked sumatriptan tablets and processes for their preparation
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase